Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma

Stopped The enrollment was terminated early because the premature analysis found similar response in the two arms.

Conditions

• Neuroendocrine Carcinoma

Interventions

• DRUG: irinotecan cisplatin
• DRUG: Etoposide cisplatin

Sponsor

Peking University